These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11522662)

  • 1. Isolation and functional characterization of recombinant GAD65 autoantibodies derived by IgG repertoire cloning from patients with type 1 diabetes.
    Jury K; Söhnlein P; Vogel M; Richter W
    Diabetes; 2001 Sep; 50(9):1976-82. PubMed ID: 11522662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs.
    Padoa CJ; Banga JP; Madec AM; Ziegler M; Schlosser M; Ortqvist E; Kockum I; Palmer J; Rolandsson O; Binder KA; Foote J; Luo D; Hampe CS
    Diabetes; 2003 Nov; 52(11):2689-95. PubMed ID: 14578287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplicity of the antibody response to GAD65 in Type I diabetes.
    Gilliam LK; Binder KA; Banga JP; Madec AM; Ortqvist E; Kockum I; Luo D; Hampe CS
    Clin Exp Immunol; 2004 Nov; 138(2):337-41. PubMed ID: 15498046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.
    Falorni A; Gambelunghe G; Forini F; Kassi G; Cosentino A; Candeloro P; Bolli GB; Brunetti P; Calcinaro F
    J Clin Endocrinol Metab; 2000 Jan; 85(1):309-16. PubMed ID: 10634404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.
    Hampe CS; Nalini R; Maldonado MR; Hall TR; Garza G; Iyer D; Balasubramanyam A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):462-7. PubMed ID: 17090641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.
    Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Kockum I; Rolandsson O; Landin-Olsson M; Törn C; Persson B; Lernmark A
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4671-9. PubMed ID: 11134126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
    Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
    Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of human monoclonal autoantibodies to glutamic acid decarboxylase.
    Hayakawa N; Premawardhana LD; Powell M; Masuda M; Arnold C; Sanders J; Evans M; Chen S; Jaume JC; Baekkeskov S; Smith BR; Furmaniak J
    Autoimmunity; 2002 Aug; 35(5):343-55. PubMed ID: 12515289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.
    Reijonen H; Daniels TL; Lernmark A; Nepom GT
    Diabetes; 2000 Oct; 49(10):1621-6. PubMed ID: 11016444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes.
    Ronkainen MS; Hoppu S; Korhonen S; Simell S; Veijola R; Ilonen J; Simell O; Knip M
    Eur J Endocrinol; 2006 Oct; 155(4):633-42. PubMed ID: 16990664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion proteins for combined analysis of autoantibodies to the 65-kDa isoform of glutamic acid decarboxylase and islet antigen-2 in insulin-dependent diabetes mellitus.
    Rickert M; Seissler J; Dangel W; Lorenz H; Richter W
    Clin Chem; 2001 May; 47(5):926-34. PubMed ID: 11325898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset.
    Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Persson B; Lernmark A
    J Autoimmun; 2002 Feb; 18(1):49-53. PubMed ID: 11869046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.
    Schlosser M; Banga JP; Madec AM; Binder KA; Strebelow M; Rjasanowski I; Wassmuth R; Gilliam LK; Luo D; Hampe CS
    Diabetologia; 2005 May; 48(5):922-30. PubMed ID: 15834701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
    Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.
    Falorni A; Ackefors M; Carlberg C; Daniels T; Persson B; Robertson J; Lernmark A
    Diabetologia; 1996 Sep; 39(9):1091-8. PubMed ID: 8877294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
    Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
    J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.
    Richter W; Shi Y; Baekkeskov S
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2832-6. PubMed ID: 7681990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
    Walikonis JE; Lennon VA
    Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.
    Al-Bukhari TA; Radford PM; Bouras G; Davenport C; Trigwell SM; Bottazzo GF; Lai M; Schwartz HL; Tighe PJ; Todd I
    Clin Exp Immunol; 2002 Oct; 130(1):131-9. PubMed ID: 12296864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.